Full Length Research Paper
References
|
Angamo MT, Wabe NT (2012). Knowledge, Attitude and Practice of Adverse Drug Reaction reporting among health professionals in South West Ethiopia. TAF. Prev. Med. Bull. 11(4):397-406 |
|
|
Ernst FR, Grizzle AJ (2001). Drug related Morbidity and Mortality: Updating the cost of illness Model. J. Am. Pharm. Assoc. (Wash). 41(2):192-199. |
|
|
Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ (2006). Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 29(4):331-340. |
|
|
Kamtane RA, Jayawardhani V (2012). Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: A pharmacoepidemiological study. Asian J. Pharm. Clin. Res. 5(3):210-214. |
|
|
Kazeam A, Jacob O (2009). Perceptions of Doctors to Adverse Drug Reaction reporting in a teaching Hospital in Lagos, Nigeria. BMC Clin. Pharmacol. 9:14. |
|
|
Kohn LT, Corrigan JM, Donaldson MS (2000). To err is human: building a safer health system (Vol. 6). National Academies Press. |
|
|
Lazarou J, Pomeranz BH, Corey PN (1998). Incidence of Adverse Drug Events in Hospitalized Patients: A Meta-analysis of prospective studies. JAMA 279(15):1200-1205. |
|
|
Lundkvist J, Jönsson B. (2004). Pharmacoeconomics of adverse drug reactions. Fundam. Clin. Pharmacol. 18(3):275-280. |
|
|
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981). A method for estimating probability of adverse drug reactions. Clin. Pharmacol. Ther. 30(2):239-245. |
|
|
Parker CW (1983). Allergic reaction in man. Pharmacol. Rev. 34:85-194. |
|
|
Rawlings MD, Thompson JP (1977). Pathogenesis of adverse drug reactions. Textbook of adverse drug reactions. Oxford University Press, Oxford. 44p. |
|
|
Rehans H, Vasudeuk T (2002). Knowledge, attitude and practices of medical students and prescribers on adverse drug reaction monitoring. Natl. Med. J. India 15(1):24-26. |
|
|
Santosh KC, Pramote T, Sarun G, Ralph E (2013). Attitudes among health care professionals to the reporting of adverse drug reaction in Nepal. BMC Pharmacol. Toxicol.14:16. |
|
|
Toklu HZ, Uysal MK (2008). Knowledge and Attitude of Turkish community pharmacists towards Pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 30(5):556-562. |
|
|
Wiffen P, Gill M, Edwards J, Moore A (2002). Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier Extra 101(4):1-15. |
|
|
World Health Organization (1972). International drug monitoring: The role of national centers. WHO technical report. Geneva: Switzerland. |
|
|
World Health Organization (2000). Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala: UppsalaMonitoring Centre. |
|
|
World Health Organization (2001). A Guide line to detecting and reporting adverse drug reaction. WHO report Geneva: Switzerland. |
|
|
World Health Organization (2006). The Safety of Medicines in Public Health Programmes: Pharmacovigilance and essential tool. Geneva: Switzerland. |
|
|
Wysowski DK, Swartz L. (2005). Adverse drug event surveillance and drug withdrawls in United states, 1969-2002. Importance of reporting suspected reactions. Arch. Intern. Med. 165(12):1363-1369. |
|
|
Zolezzi M, Parsotam N (2005). Adverse drug reporting in New Zeeland: Implications for Pharmacists. Ther. Clin. Risk. Manage. 1(3):181-188 |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
